0001077183-21-000087.txt : 20210303 0001077183-21-000087.hdr.sgml : 20210303 20210303201940 ACCESSION NUMBER: 0001077183-21-000087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McKenzie Kathryn B CENTRAL INDEX KEY: 0001720001 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 21711984 MAIL ADDRESS: STREET 1: 12780 WESTLINKS DRIVE CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 4 1 wf-form4_161482075291006.xml FORM 4 X0306 4 2021-03-01 0 0001077183 NEOGENOMICS INC NEO 0001720001 McKenzie Kathryn B 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 0 1 0 0 Chief Financial Officer Common Stock 2021-03-01 4 F 0 169 0 D 7760 D Common Stock 2021-03-02 4 F 0 432 0 D 7328 D Common Stock 2021-03-02 4 A 0 6207 0 A 13535 D Stock Option (Right to Buy) 9.07 2022-10-18 Common Stock 25000.0 25000 D Stock Option (Right to Buy) 8.03 2023-02-26 Common Stock 40000.0 40000 D Stock Option (Right to Buy) 19.6 2024-03-01 Common Stock 13894.0 13894 D Stock Option (Right to Buy) 28.33 2027-03-02 Common Stock 37514.0 37514 D Stock Option (Right to Buy) 53.17 2021-03-02 4 A 0 35171 53.17 A 2028-03-02 Common Stock 35171.0 35171 D Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock. Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock. On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. On February 26, 2018, Ms. McKenzie was granted 48,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. On March 1, 2019, Ms. McKenzie was granted 13,894 stock options. These options vest ratably over the first four anniversary dates of the grant date. On March 2, 2020, Ms. McKenzie was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date. On March 2, 2021, Ms. McKenzie was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date. /s/ Kathryn B McKenzie 2021-03-03